M R Jacobs

2.0k total citations
37 papers, 1.6k citations indexed

About

M R Jacobs is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, M R Jacobs has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 15 papers in Pharmacology and 12 papers in Molecular Medicine. Recurrent topics in M R Jacobs's work include Pneumonia and Respiratory Infections (15 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Resistance in Bacteria (12 papers). M R Jacobs is often cited by papers focused on Pneumonia and Respiratory Infections (15 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Resistance in Bacteria (12 papers). M R Jacobs collaborates with scholars based in United States, South Africa and Japan. M R Jacobs's co-authors include Peter C. Appelbaum, Shigeru Yamabe, Scott F. Dowell, Daniel M. Musher, Daniel B. Jernigan, Alexander Rakowsky, Benjamin Schwartz, G. Scott Giebink, Jay C. Butler and Saralee Bajaksouzian and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.

In The Last Decade

M R Jacobs

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M R Jacobs United States 20 939 553 410 360 312 37 1.6k
Glenn A. Pankuch United States 28 1.5k 1.6× 1.1k 2.0× 898 2.2× 333 0.9× 612 2.0× 75 2.5k
Kenneth J. Tack United States 24 622 0.7× 490 0.9× 271 0.7× 120 0.3× 684 2.2× 45 1.6k
C H Nightingale United States 26 962 1.0× 1.2k 2.2× 576 1.4× 136 0.4× 660 2.1× 70 2.3k
Burt R. Meyers United States 27 750 0.8× 732 1.3× 453 1.1× 88 0.2× 671 2.2× 78 2.0k
Holly K. Huynh United States 14 904 1.0× 477 0.9× 370 0.9× 215 0.6× 356 1.1× 21 1.3k
Kristopher P. Heilmann United States 25 1.4k 1.5× 418 0.8× 313 0.8× 539 1.5× 874 2.8× 32 2.7k
Keisuke Sunakawa Japan 24 1.7k 1.8× 396 0.7× 468 1.1× 1.0k 2.9× 642 2.1× 179 2.6k
Eugenio A. Debbia Italy 21 667 0.7× 312 0.6× 541 1.3× 151 0.4× 577 1.8× 94 1.6k
M. Roussel‐Delvallez France 14 713 0.8× 311 0.6× 606 1.5× 170 0.5× 271 0.9× 43 1.6k
José Campos Spain 26 991 1.1× 255 0.5× 870 2.1× 686 1.9× 200 0.6× 39 1.8k

Countries citing papers authored by M R Jacobs

Since Specialization
Citations

This map shows the geographic impact of M R Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M R Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M R Jacobs more than expected).

Fields of papers citing papers by M R Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M R Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M R Jacobs. The network helps show where M R Jacobs may publish in the future.

Co-authorship network of co-authors of M R Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of M R Jacobs. A scholar is included among the top collaborators of M R Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M R Jacobs. M R Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, M R. (2007). Clinical significance of antimicrobial resistance in Streptococcus pneumoniae.. PubMed. 97(11 Pt 3). 1133–40. 10 indexed citations
2.
Joloba, Moses, Anne Windau, Saralee Bajaksouzian, et al.. (2001). Pneumococcal Conjugate Vaccine Serotypes ofStreptococcus pneumoniaeIsolates and the Antimicrobial Susceptibility of Such Isolates in Children with Otitis Media. Clinical Infectious Diseases. 33(9). 1489–1494. 87 indexed citations
3.
Dagan, Ron, Samuel E. McLinn, Nazha Abughali, et al.. (2000). Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. The Pediatric Infectious Disease Journal. 19(2). 95–104. 150 indexed citations
4.
5.
Pankuch, Glenn A., Dianne B. Hoellman, M R Jacobs, & Peter C. Appelbaum. (1999). Antipneumococcal activity of MEN 10700, a new penem, compared with other compounds, by MIC and time–kill kinetics. Journal of Antimicrobial Chemotherapy. 44(3). 381–384. 11 indexed citations
6.
Dowell, Scott F., Jay C. Butler, G. Scott Giebink, et al.. (1999). Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. The Pediatric Infectious Disease Journal. 18(1). 1–9. 393 indexed citations
7.
Jacobs, M R & Saralee Bajaksouzian. (1997). Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid. Diagnostic Microbiology and Infectious Disease. 28(3). 105–112. 18 indexed citations
8.
Lazarus, Hillard M., Richard J. Creger, Rasim Gucalp, et al.. (1996). Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patients. International Journal of Antimicrobial Agents. 7(2). 85–91. 3 indexed citations
9.
Jacobs, M R. (1992). Treatment and Diagnosis of Infections Caused by Drug-Resistant Streptococcus pneumoniae. Clinical Infectious Diseases. 15(1). 119–127. 152 indexed citations
10.
Jacobs, M R. (1991). Evaluation of the bactericidal activity of temafloxacin. The American Journal of Medicine. 91(6). S31–S34. 7 indexed citations
11.
Lass, Jonathan H., et al.. (1991). Topical fluoroquinolones: Antimicrobial activity andin vitrocorneal epithelial toxicity. Current Eye Research. 10(6). 557–563. 46 indexed citations
12.
Jacobs, M R, et al.. (1989). In VitroActivity of YTR 830. Journal of Chemotherapy. 1(3). 151–154. 2 indexed citations
13.
Butler, Thomas, M R Jacobs, & David Farhi. (1988). Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin. Antimicrobial Agents and Chemotherapy. 32(5). 791–792. 4 indexed citations
14.
Jacobs, M R, et al.. (1984). Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin. Antimicrobial Agents and Chemotherapy. 26(4). 580–582. 103 indexed citations
15.
Appelbaum, Peter C., et al.. (1984). Comparative evaluation of the API 20S system and the automicrobic system gram-positive identification card for species identification of streptococci. Journal of Clinical Microbiology. 19(2). 164–168. 28 indexed citations
16.
Shlaes, David M., Jennifer L. Marino, & M R Jacobs. (1984). Infection caused by vancomycin-resistant Streptococcus sanguis II. Antimicrobial Agents and Chemotherapy. 25(4). 527–528. 40 indexed citations
17.
Acar, J. F., G Altmann, L Chao, et al.. (1982). Laboratory Surveillance of Synergy Between and Resistance to Trimethoprim and Sulfonamides. Clinical Infectious Diseases. 4(2). 351–357. 16 indexed citations
18.
Jacobs, M R, Miklos Gaspar, Roy M. Robins‐Browne, & H. J. Koornhof. (1980). Antimicrobial susceptibility testing of pneumococci. Journal of Antimicrobial Chemotherapy. 6(1). 53–64. 39 indexed citations
19.
Koornhof, H J & M R Jacobs. (1979). Resistant pneumococcal infections.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(5). 69–74. 5 indexed citations
20.
Robins‐Browne, Roy M., M R Jacobs, & H J Koornhof. (1978). Escherichia coli gastro-enteritis in adults.. PubMed. 53(3). 93–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026